Tobacco return on investment tool

NICE has developed a tobacco return on investment tool to help decision making in tobacco control at local and sub-national levels. The tool evaluates a portfolio of tobacco control interventions and models the economic returns that can be expected in different payback timescales. Different interventions, including pharmacotherapies and support and advice, can be mixed and matched to see which intervention portfolio or package provides the best ‘value for money’, compared with ‘no-services’ or any other specified package.  The tool is to support commissioners and policy makers, in local authorities and the NHS, in their investment decisions.


The World Alzheimer Report 2015: ‘The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends’ has found that there are currently around 46.8 million people living with dementia around the world, with numbers projected to nearly double every 20 years, increasing to 74.7 million by 2030 and 131.5 million by 2050. There are over 9.9 million new cases of dementia each year worldwide, implying one new case every 3.2 seconds.


The report shows that the current annual societal and economic cost of dementia is US $818 billion, and it is expected to become a trillion dollar disease in just three years’ time. The findings show that the cost of dementia has increased by 35% since the 2010 World Alzheimer Report.

New guidelines for diabetes care

New diabetes guidance includes tighter targets for blood sugar levels to help reduce variation in the management and care of condition.

nice quote

The National Institute for Health and Care Excellence (NICE) is issuing new guidelines to improve the management of diabetes in adults and children. It includes aiming for tighter blood sugar control to help manage the condition.

The update from NICE is designed to address the problem of varying standards of diabetes care in different parts of the country.

The new guidance covers type 1 diabetes in adults, type 1 and type 2 diabetes in children and young people, and diabetic foot care.


The Queen’s Nursing Institute has created a new online learning resource for nurses who are new to working in the school nursing service.

The new learning resource has been developed specifically for the school nurse environment and contains 11 chapters, on subjects including safeguarding, integrating children with special health needs, working with other community professionals, and career development.  As with the original ‘Transition’ resource, the new book is designed to be used with a mentor and is based on reflective learning principles.


Click here to read the press release. 

Universal flu vaccine a step closer as scientists create experimental jabs

Annual vaccinations could be a thing of the past as scientists have successfully tested vaccines on animals infected with different strains of influenza

flu virus

A universal flu vaccine that protects against multiple strains of the virus is a step closer after scientists created experimental jabs that work in animals. The vaccines prevented deaths or reduced symptoms in mice, ferrets and monkeys infected with different types of flu, raising hopes for a reliable alternative to the seasonal vaccine.

Doctors hope that a universal flu vaccine would do away with the need for people at risk to have flu jabs every year, and even protect the public from dangerous, potentially pandemic, strains that jump from birds or pigs into humans..

During the last flu season, mutations in the HA molecule on one of the most common circulating strains, H3N2, meant that the seasonal flu vaccine offered little protection. Public Health England said in February that the less effective vaccine was likely to have been behind a steep rise in flu deaths.

In two studies reported on Monday, separate research teams describe how they created novel flu vaccines that target the “stem” of the HA molecule instead of the head. The stem of the HA molecule is similar across different flu strains and mutates far less often. One of the teams, led by Barney Graham at the National Institutes of Health in Maryland, created their vaccine by attaching part of a flu virus’s HA stem to tiny balls of protein. These protein nanoparticles kept the stem intact and made it easy for the immune system to spot once it was injected. In lab tests, one version of the vaccine completely protected mice and partially protected ferrets from injections of H5N1 bird flu virus, which was fatal in unvaccinated animals. The H5N1 flu strain has killed more than 400 people since 2003, most of whom caught the virus from infected poultry.

Read the full article via Universal flu vaccine a step closer as scientists create experimental jabs | Science | The Guardian.

Care and treatment reviews to become ‘business as usual’

NHS England has today set out how it intends that reviews of care and treatment arrangements for people with learning disabilities are to be embedded across the health and care system.

NHS England has today set out how it intends that reviews of care and treatment arrangements for people with learning disabilities are to be embedded across the health and care system.

Care and Treatment Reviews (CTRs) were developed as part of NHS England’s commitment to improving the care of people with learning disabilities or autism. They aim to reduce unnecessary admissions and lengthy stays in specialist hospitals, and have been rolling out since October 2014; over 1,400 people had their care reviewed up to March this year, with hundreds more since.

They bring those responsible for the care of those who are in, or at risk of being admitted to, specialist hospitals around the table with the individual themselves and their families, as well as independent clinicians and experts by experience, to ensure that the care needs of that individual are being met.

Care and Treatment Review: Policy and Guidance (also available in easy read) has been produced by building on the learning from the reviews which have taken place so far, including extensive engagement with people with learning disabilities, their representatives and their families.

The document will help local Clinical Commissioning Groups and NHS England commissioners implement the recommendation from this learning that CTRs should become ‘business as usual’.

via NHS England » Care and treatment reviews to become ‘business as usual’.